Metastat Stock Net Income
| MTST Stock | USD 0.0006 0.00 0.00% |
As of the 9th of February, MetaStat secures the Risk Adjusted Performance of 0.0974, standard deviation of 16.53, and Mean Deviation of 3.99. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MetaStat, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from MetaStat's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MetaStat's valuation are summarized below:MetaStat does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. MetaStat |
MetaStat 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MetaStat's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MetaStat.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in MetaStat on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding MetaStat or generate 0.0% return on investment in MetaStat over 90 days. MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment... More
MetaStat Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MetaStat's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MetaStat upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1037 | |||
| Maximum Drawdown | 147.62 |
MetaStat Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MetaStat's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MetaStat's standard deviation. In reality, there are many statistical measures that can use MetaStat historical prices to predict the future MetaStat's volatility.| Risk Adjusted Performance | 0.0974 | |||
| Jensen Alpha | 1.93 | |||
| Total Risk Alpha | 0.1591 | |||
| Treynor Ratio | (1.08) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MetaStat's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MetaStat February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0974 | |||
| Market Risk Adjusted Performance | (1.07) | |||
| Mean Deviation | 3.99 | |||
| Coefficient Of Variation | 916.59 | |||
| Standard Deviation | 16.53 | |||
| Variance | 273.34 | |||
| Information Ratio | 0.1037 | |||
| Jensen Alpha | 1.93 | |||
| Total Risk Alpha | 0.1591 | |||
| Treynor Ratio | (1.08) | |||
| Maximum Drawdown | 147.62 | |||
| Skewness | 7.97 | |||
| Kurtosis | 64.46 |
MetaStat Backtested Returns
MetaStat is out of control given 3 months investment horizon. MetaStat has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11 % return per unit of risk over the last 3 months. We are able to interpolate and collect sixteen different technical indicators, which can help you to evaluate if expected returns of 1.86% are justified by taking the suggested risk. Use MetaStat Risk Adjusted Performance of 0.0974, standard deviation of 16.53, and Mean Deviation of 3.99 to evaluate company specific risk that cannot be diversified away. MetaStat holds a performance score of 8 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -1.66, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning MetaStat are expected to decrease by larger amounts. On the other hand, during market turmoil, MetaStat is expected to outperform it. Use MetaStat risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and day median price , to analyze future returns on MetaStat.
Auto-correlation | -0.13 |
Insignificant reverse predictability
MetaStat has insignificant reverse predictability. Overlapping area represents the amount of predictability between MetaStat time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MetaStat price movement. The serial correlation of -0.13 indicates that less than 13.0% of current MetaStat price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.13 | |
| Spearman Rank Test | 0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, MetaStat reported net income of (3.18 Million). This is 100.93% lower than that of the Life Sciences Tools & Services sector and 104.54% lower than that of the Health Care industry. The net income for all United States stocks is 100.56% higher than that of the company.
MetaStat Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MetaStat's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of MetaStat could also be used in its relative valuation, which is a method of valuing MetaStat by comparing valuation metrics of similar companies.MetaStat is currently under evaluation in net income category among its peers.
MetaStat Fundamentals
| Return On Asset | -2.23 | |||
| Operating Margin | (152.38) % | |||
| Current Valuation | 703.66 K | |||
| Shares Outstanding | 5.88 M | |||
| Shares Owned By Insiders | 1.56 % | |||
| Price To Earning | (0.78) X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 23.3 K | |||
| Gross Profit | (1.23 M) | |||
| EBITDA | (2.97 M) | |||
| Net Income | (3.18 M) | |||
| Cash And Equivalents | 316.93 K | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 1000 K | |||
| Debt To Equity | 839.50 % | |||
| Current Ratio | 0.16 X | |||
| Book Value Per Share | (0.26) X | |||
| Cash Flow From Operations | (2.74 M) | |||
| Earnings Per Share | (0.61) X | |||
| Target Price | 18.45 | |||
| Beta | -3.26 | |||
| Market Capitalization | 205 | |||
| Total Asset | 729.63 K | |||
| Retained Earnings | (25.48 M) | |||
| Working Capital | (3.27 M) | |||
| Current Asset | 190 K | |||
| Current Liabilities | 3.46 M | |||
| Z Score | -65.6 | |||
| Net Asset | 729.63 K |
About MetaStat Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MetaStat's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MetaStat using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MetaStat based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MetaStat Pink Sheet Analysis
When running MetaStat's price analysis, check to measure MetaStat's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaStat is operating at the current time. Most of MetaStat's value examination focuses on studying past and present price action to predict the probability of MetaStat's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaStat's price. Additionally, you may evaluate how the addition of MetaStat to your portfolios can decrease your overall portfolio volatility.